Deprescribing near end of life — DGM MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Atorvastatin
A statin for long-term prevention should be reviewed when a patient is dying and cannot swallow. Morphine, hyoscine, mouth care and breakthrough analgesia address current comfort needs. Medication review near end of life should prioritise immediate symptom benefit.
Reference: NICE NG31; NICE NG56